Chemical Targeting of the ATXN1 aa99–163 Interaction Site Suppresses polyQ-Expanded Protein Dimerization
Saved in:
| Main Authors: | Ioannis Gkekas, Katerina Pliatsika, Stelios Mylonas, Sotirios Katsamakas, Apostolos Axenopoulos, Simona Kostova, Erich E. Wanker, Dimitra Hadjipavlou-Litina, Konstantinos Xanthopoulos, Petros Daras, Spyros Petrakis |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
American Chemical Society
2025-06-01
|
| Series: | ACS Omega |
| Online Access: | https://doi.org/10.1021/acsomega.5c02465 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Multitarget Compounds Designed for Alzheimer, Parkinson, and Huntington Neurodegeneration Diseases
by: Eleftheria-Emmanouela Katsoulaki, et al.
Published: (2025-06-01) -
The role of interruptions in polyQ in the pathology of SCA1.
by: Rajesh P Menon, et al.
Published: (2013-01-01) -
UBL3 Interacts with PolyQ-Expanded Huntingtin Fragments and Modifies Their Intracellular Sorting
by: Soho Oyama, et al.
Published: (2024-10-01) -
Identification of Splicing Regulatory Activity of ATXN1 and Its Associated Domains
by: Ai Ohki, et al.
Published: (2025-05-01) -
CAG-targeted brain-permeable therapy tested in biallelic humanized polyQ mouse models
by: Magdalena Surdyka, et al.
Published: (2025-06-01)